An amendment to this paper has been published and can be accessed via the original article.
View Article and Find Full Text PDFBackground: The current antimicrobial therapy is still important for the treatment of pneumonia due to MRSA infection, but there are some limitations, including the route of administration, side effect profile, and increased microbial resistance patterns. Therefore, we investigated whether BV, which shows a strong antimicrobial effect against MRSA, would be effective in a pneumonia model.
Methods: In vitro, we checked MIC, qRT-PCR, western blot, ELISA, LDH-assay.